265 related articles for article (PubMed ID: 22122185)
21. The pharmacodynamics of vecuronium in chronic renal failure patients: the impact of different priming doses.
Tarbeeh GA; Othman MM
Ren Fail; 2012; 34(7):827-33. PubMed ID: 22607043
[TBL] [Abstract][Full Text] [Related]
22. Preserved heart rate variability during therapeutic hypothermia correlated to 96 hrs neurological outcomes and survival in a pig model of cardiac arrest.
Li Y; Ristagno G; Guan J; Barbut D; Bisera J; Weil MH; Tang W
Crit Care Med; 2012 Feb; 40(2):580-6. PubMed ID: 21926589
[TBL] [Abstract][Full Text] [Related]
23. Recovery of train-of-four ratio to 0.70 and 0.90 is delayed in type 2 diabetes with vecuronium-induced neuromuscular block.
Nitahara K; Sugi Y; Shigematsu K; Haraga I; Abe S; Higa K
Eur J Anaesthesiol; 2013 Feb; 30(2):80-4. PubMed ID: 23172246
[TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamic interaction between pantoprazole and vecuronium at neuromuscular junction.
Vadgama VK; Patel YA; Patel TK; Tripathi CB
Auton Autacoid Pharmacol; 2011; 31(1-2):31-5. PubMed ID: 21342416
[TBL] [Abstract][Full Text] [Related]
25. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
[TBL] [Abstract][Full Text] [Related]
26. Rocuronium bromide in the ICU: dose finding and pharmacokinetics.
Khuenl-Brady KS; Sparr H; Pühringer F; Agoston S
Eur J Anaesthesiol Suppl; 1995 Sep; 11():79-80. PubMed ID: 8557012
[TBL] [Abstract][Full Text] [Related]
27. Use of Neuromuscular Blockers During Therapeutic Hypothermia After Cardiac Arrest: A Nursing Protocol.
Boulila C; Ben Abdallah S; Marincamp A; Coic V; Lauverjat R; Ericher N; Bougouin W; Mira JP; Cariou A; Geri G
Crit Care Nurse; 2016 Dec; 36(6):33-40. PubMed ID: 27908944
[TBL] [Abstract][Full Text] [Related]
28. Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study.
Roberts JA; Boots R; Rickard CM; Thomas P; Quinn J; Roberts DM; Richards B; Lipman J
J Antimicrob Chemother; 2007 Feb; 59(2):285-91. PubMed ID: 17135183
[TBL] [Abstract][Full Text] [Related]
29. Frusemide administration in critically ill patients by continuous compared to bolus therapy.
Ostermann M; Alvarez G; Sharpe MD; Martin CM
Nephron Clin Pract; 2007; 107(2):c70-6. PubMed ID: 17890871
[TBL] [Abstract][Full Text] [Related]
30. [Diltiazem potentiates the neuromuscular blockade by vecuronium in humans].
Takasaki Y; Naruoka Y; Shimizu C; Ochi G; Nagaro T; Arai T
Masui; 1995 Apr; 44(4):503-7. PubMed ID: 7776513
[TBL] [Abstract][Full Text] [Related]
31. Model-driven closed-loop feedback infusion of atracurium and vecuronium during hypothermic cardiopulmonary bypass.
Kansanaho M; Hynynen M; Olkkola KT
J Cardiothorac Vasc Anesth; 1997 Feb; 11(1):58-61. PubMed ID: 9058222
[TBL] [Abstract][Full Text] [Related]
32. [Pretreatment with lidocaine accelerates onset of vecuronium-induced neuromuscular blockade].
Nonaka A; Sugawara T; Suzuki S; Masamune T; Kumazawa T
Masui; 2002 Aug; 51(8):880-3. PubMed ID: 12229137
[TBL] [Abstract][Full Text] [Related]
33. A randomized controlled double blind study on quick intubation regimen using vecuronium priming infusion technique with the use of patient controlled analgesia pump vs bolus priming technique.
Tripathi M; Pandey M
Indian J Med Res; 2005 Oct; 122(4):319-23. PubMed ID: 16394324
[TBL] [Abstract][Full Text] [Related]
34. Effects of olprinone on neuromuscular blockade caused by vecuronium.
Katayama T; Saitoh Y; Nemoto C; Hirama T; Isosu T; Murakawa M
Fukushima J Med Sci; 2007 Dec; 53(2):61-9. PubMed ID: 18402286
[TBL] [Abstract][Full Text] [Related]
35. Nicorandil accelerates recovery of neuromuscular block caused by vecuronium.
Saitoh Y; Kaneda K; Fujii Y; Oshima T
Can J Anaesth; 2001 Jan; 48(1):28-33. PubMed ID: 11212045
[TBL] [Abstract][Full Text] [Related]
36. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients.
Rudis MI; Sikora CA; Angus E; Peterson E; Popovich J; Hyzy R; Zarowitz BJ
Crit Care Med; 1997 Apr; 25(4):575-83. PubMed ID: 9142020
[TBL] [Abstract][Full Text] [Related]
37. The ulinastatin-induced effect on neuromuscular block caused by vecuronium.
Saitoh Y; Fujii Y; Oshima T
Anesth Analg; 1999 Dec; 89(6):1565-9. PubMed ID: 10589650
[TBL] [Abstract][Full Text] [Related]
38. Observations of the potency and duration of vecuronium in isoflurane-anesthetized horses.
Martin-Flores M; Pare MD; Adams W; Campoy L; Gleed RD
Vet Anaesth Analg; 2012 Jul; 39(4):385-9. PubMed ID: 22642379
[TBL] [Abstract][Full Text] [Related]
39. Paralysis in the critically ill: intermittent bolus pancuronium compared with continuous infusion.
de Lemos JM; Carr RR; Shalansky KF; Bevan DR; Ronco JJ
Crit Care Med; 1999 Dec; 27(12):2648-55. PubMed ID: 10628604
[TBL] [Abstract][Full Text] [Related]
40. Large bolus dose vs. continuous infusion of cisatracurium during hypothermic cardiopulmonary bypass surgery.
Cammu G; Boussemaere V; Foubert L; Hendrickx J; Coddens J; Deloof T
Eur J Anaesthesiol; 2005 Jan; 22(1):25-9. PubMed ID: 15816569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
